Top 15 Drug Spend

2016 Harvard Pilgrim Health Care

  • Humira
  • Harvoni
  • Enbrel
  • Copaxone
  • Tecfidera
  • Lantus Solostar
  • Flovent Diskus
  • Auvi-Q, EpiPen
  • Descovy, Truvada
  • Remicade
  • Rituxan
  • Herceptin
  • Neulasta
  • Gamastan
  • Avastin
for employers and health plans
Lower costs and better health outcomes, it's in our DNA

RxMapper’s personalized medications lead to healthier, happier, more productive lives — and reduce costs.

Increased Productivity

Productivity losses related to personal and family health problems cost U.S. employers $1,685 per employee per year, or $225.8 billion annually. 7

Increased Productivity
Reduced Absenteeism

Reduced Absenteeism

Approximately 8 million U.S. workers miss work each month because of an illness. 8

Happier Employees

89% of workers at companies that support well-being initiatives are more likely to recommend their company. 9

Happier Employees

RxMapper's Personalized Solutions

Customized Recommendations

Customized Recommendations

Each Client receive customized recommendations that identifies which Members would benefit the most from RxMapper’s Personalized Medications Services and should be prioritized for DNA sequencing and analysis.

Controlled Implementation

Controlled Implementation

The Client controls the timing and the roll out of RxMapper’s Personalized Medication Services in stages or as a comprehensive offering to all Members.

No Risk, Guaranteed Savings

No Risk, Guaranteed Savings

If a Client and its Members follow RxMapper’s process and recommendations and the shared savings at the end of the year do not exceed the cost of DNA sequencing, RxMapper will refund the Client the difference.

Harvard Pilgrim case Review
Harvard Pilgrim Health Care
In 2018, Health Affairs published the top 15 drug spend by Harvard Pilgrim Health Care.

Comprehensive Coverage

RxMapper covers all top 15 drugs.

See The List

Wasted Spending

RxMapper covers all 15 drugs and found that over 22% of the $159.8 million spent on these drugs was wasted on patients who do not respond to the drugs.

Cost Savings

If these patients had been sequenced and analyzed by RxMapper, Harvard Pilgrim could have saved $35.4 million and delivered better health outcomes to its members.

Interested In Learning More?
Contact Us